Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity

Erstveröffentlichung
2011
Metadata only
Search for full text

Wissenschaftlicher Artikel

Autoren
Taskesen, Erdogan
Bullinger, Lars
Corbacioglu, Andrea
Sanders, Mathijs A.
Erpelinck, Claudia A. J.
et al.
Institutionen
UKU. Klinik für Innere Medizin III
Erschienen in
Blood ; 117 (2011), 8. - S. 2469-2475. - ISSN 0006-4971
Link zur Veröffentlichung
https://dx.doi.org/10.1182/blood-2010-09-307280
Förderinformationen
Center for Translational Molecular Medicine
Else Kroner-Fresenius-Stiftung [P38/05//A49/05//F03]
Network of Competence Acute and Chronic Leukemias [01GI9981]
Bundesministerium fur Bildung und Forschung, Germany [01KG0605]
Schlagwörter
acute myeloid-leukemia; colony-stimulating factor; binding-protein-alpha; c/ebp-alpha; myelodysplastic syndromes; consolidation therapy; favorable prognosis; normal karyotype; younger adults; trial
DDC-Sachgruppe
DDC 610 / Medicine & health
Metadata
Zur Langanzeige